Defunct Company
Total Trials
1
As Lead Sponsor
0
As Collaborator
Total Enrollment
45
NCT06866275
Suramin for the Treatment of Autism Trial: KZ101 in a Male Pediatric Population With Autism Spectrum Disorder (ASD)
Phase: Phase 2
Role: Collaborator
Start: Apr 9, 2025
Completion: Apr 30, 2028